Glaxo profits up 11 percent on emerging markets

GlaxoSmithKline, the world's second largest drug maker by revenues, posted an 11 percent rise in second quarter profit on Wednesday after strong pharmaceutical sales in emerging markets helped offset the impact of generic competition in the United States.... Sponsored Topics: GlaxoSmithKline - United States - Pharmaceutical industry - Business - pharmaceutical